Various types of adult stem cells in regenerative medicines have generated considerable attention and interest among clinicians and the industries at large. There has been a groundswell of interest in stem cell-targeted therapies in cardiology and neurology among researchers. However, the vast therapeutic benefits have still lack substantial scientific evidence and consistent clinical backing. Challenges of careful packaging and processing before they are used apart from significant risks natural stem cells entail are factors that account for their limited therapeutic efficacy. In addition, they suffer from limited durability. Hence, there has been a surge in research on synthetic stem cells in recent years so as to get over some of these challenges. Synthetic stem cells allow flexibility in manufacturing processes, are less delicate in handling and can be made to bypass the immune system. Moreover, they have comparable therapeutic benefits offered by natural stem cells in tissue repair. One of the areas where synthetic stems cells are witnessing a large potential is cardiovascular diseases.
The rising incidence and substantial prevalence of various cardiovascular diseases in various parts of the world have spurred research in synthetic versions of cardiac stem cells (CSCs). The emerging focus on synthetic stem cell–niche engineering has imparted a large momentum to the growth of the synthetic stems cells market. In 2017, scientists were able to successfully implant synthetic cardiac stem cells, particularly synthetic cell-mimicking microparticle, to repair muscle tissues damaged by heart attacks. These can be used for off-the-shelf applications. The better preservation stability and the generalization of the technology to various other types of stem cells are advantages that led to such research gaining significance in the synthetic stem cells market. In the next couple of years, such clinical research will accelerate the commercialization of cardiac synthetic stem cells.
Efforts of researchers world over to develop a platform technology to cater to multiple stem cells are expected to create new, exciting avenues for market players to capitalize on in the not-so-distant future. This will also make synthetic stem cells open for potential applications in a wide range of disease indications. However, the regulatory landscape for development and approval of synthetic stem cells are still not well-structured. This poses a genuine challenge to companies hoping for rapid commercialization of synthetic stems cells.
The study takes a critical look at key regional growth dynamics shaping the global synthetic stem cells market. The insights help stakeholders identify lucrative regions and highlight key trends that will drive some regions to emerge rapidly over the assessment timeline. Developed regions, notably North America, is expected to hold promising potential in the global synthetic stem cells market. Burgeoning clinical studies into synthetic stem cells, dovetailed by sizeable public and private funding, will help the region occupy a prominent position in the global market dynamics in the coming years. Early adoption of novel regenerative therapies will also impart fillip to the demand for synthetic stem cells in North America.
Various assessments made by the study tracks prevailing competitive dynamics and the strategies adopted by key players that can shape the future landscape of the global synthetic stem cells market. Presently there are a handful of players in the market. Key stakeholders aiming for substantial stakes in the global synthetic stems cells market are Zhengzhou University (China) and North Carolina State University (NCSU).
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with the ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making the right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through ad-hoc reports. These requests are delivered with the perfect combination of the right sense of fact-oriented problem-solving methodologies and leveraging existing data repositories.
TMR believes that the unison of solutions for client-specific problems with the right methodology of research is the key to help enterprises reach the right decision.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453
Email: [email protected]